WCCT Global, a full service CRO supporting phase I-IV development, has collaborated with Verified Clinical Trials (VCT), the largest national clinical trials database registry in the U.S., to help them enhance the capabilities of the VCT Clinical Trials Database Registry system.
This new enhancement designed in collaboration with WCCT enables the investigator to document study-participant adherence to medication schedules.
"Patient adherence to clinical research protocol procedures is critical along with returning to the investigational site for study procedures and safety assessments,” said Mel Affrime, senior vice president of WCCT. “This added enhancement now offered by VCT adds another level of security in the validity of the data that we capture for our clients.”
Mitchell Efros, MD, FACS, CEO and president of VCT, said, "The recently released study medication adherence reminder system will improve dosing compliance in clinical trials. The module has the ability to remind the research volunteer to take the medication directly through the VCT registry. There is also the option of having the research subject respond to the reminder signaling their compliance and execution of the required dosing.”
He added, “WCCT Global, one of the early subscribers to our database, has always been an industry leader in their efforts to ensure the safety of their study participants and the quality of their clinical data. It has been a pleasure working with the WCCT team to make this enhancement available to our entire network of subscribers."